These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2166 related items for PubMed ID: 2532422

  • 1. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 2. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 3. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT, Wachtel SR, Galloway MP, White FJ.
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 6. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD, Freeman AS, Chiodo LA.
    Synapse; 1988 May; 2(4):416-23. PubMed ID: 2973142
    [Abstract] [Full Text] [Related]

  • 7. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens.
    Henry DJ, White FJ.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):882-90. PubMed ID: 1890623
    [Abstract] [Full Text] [Related]

  • 8. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Apparent mediation of the stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors.
    Widzowski DV, Cory-Slechta DA.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):526-34. PubMed ID: 8355188
    [Abstract] [Full Text] [Related]

  • 12. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L, Pitts DK.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):164-76. PubMed ID: 7815330
    [Abstract] [Full Text] [Related]

  • 13. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration.
    Henry DJ, Greene MA, White FJ.
    J Pharmacol Exp Ther; 1989 Dec 10; 251(3):833-9. PubMed ID: 2557418
    [Abstract] [Full Text] [Related]

  • 15. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH, Bergstrom DA, Demo SD, Walters JR.
    Synapse; 1990 Dec 10; 5(2):83-93. PubMed ID: 2309160
    [Abstract] [Full Text] [Related]

  • 16. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D, Salah RS, Galloway MP.
    Synapse; 1991 Jul 10; 8(3):169-76. PubMed ID: 1948667
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR, Bunney BS.
    J Pharmacol Exp Ther; 1989 Mar 10; 248(3):1323-33. PubMed ID: 2564893
    [Abstract] [Full Text] [Related]

  • 18. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL.
    Mol Pharmacol; 1990 Jul 10; 38(1):92-101. PubMed ID: 1973525
    [Abstract] [Full Text] [Related]

  • 19. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
    Jiang LH, Kasser RJ, Altar CA, Wang RY.
    J Pharmacol Exp Ther; 1990 Jun 10; 253(3):1198-205. PubMed ID: 1972751
    [Abstract] [Full Text] [Related]

  • 20. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ.
    Pharmacol Biochem Behav; 1988 May 10; 30(1):189-93. PubMed ID: 2902644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 109.